Dx & Vx Co., Ltd. Logo

Dx & Vx Co., Ltd.

Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.

180400 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 금천구 디지털로 173, 금천구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Dx & Vx Co., Ltd. is a global bio-healthcare company focused on developing innovative diagnostics (Dx) and vaccines (Vx). The company leverages proprietary technologies, including a platform for long-term, room-temperature storage of mRNA vaccines and a universal Next-Generation Sequencing (NGS) platform. Its R&D pipeline targets infectious diseases, immuno-oncology, obesity, and eye diseases. In addition to its drug development, Dx & Vx provides a comprehensive suite of services to the life sciences industry, including contract development (CDO), manufacturing (CMO), sales (CSO), and companion diagnostics (CDx) development. The company also develops microbiome-based products and offers medical data services.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Dx & Vx Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-16 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 8.4 KB
2025-09-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.7 KB
2025-08-29 00:00
M&A Activity
합병등종료보고서(자산양수도)
Korean 15.2 KB
2025-08-14 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 13.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.8 MB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.1 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 2.4 MB
2025-07-30 00:00
M&A Activity
투자판단관련주요경영사항 (mRNA항암백신 공동연구 및 기술이전계약 체결)
Korean 10.7 KB
2025-07-30 00:00
M&A Activity
주요사항보고서(타법인주식및출자증권양도결정)
Korean 19.8 KB
2025-07-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 82.4 KB

Automate Your Workflow. Get a real-time feed of all Dx & Vx Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Dx & Vx Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
WAKAMOTO PHARMACEUTICAL CO.,LTD. Logo
Develops gastrointestinal and ophthalmic drugs for the health challenges of an aging society.
Japan 4512
WELLBIOTEC CO.,LTD Logo
Diversified in biopharma, EV chargers, and lithium supply for batteries.
South Korea 010600
WHANIN PHARM CO.,LTD Logo
Develops and sells pharmaceuticals, specializing in CNS, cardiovascular, and GI drugs.
South Korea 016580
WooGeneB&GCO.,Ltd Logo
Manufactures veterinary medicines, vaccines, and supplements for livestock and aquatic animals.
South Korea 018620
Xbrane Biopharma Logo
Develops affordable biosimilars for serious diseases using patented, high-yield production tech.
Sweden XBRANE
Xintela AB Logo
Develops stem cell therapies for osteoarthritis and venous leg ulcers using proprietary technology.
Sweden XINT
Xspray Pharma Logo
Develops improved cancer drugs (PKIs) using patented tech to circumvent secondary patents.
Sweden XSPRAY
Y.B Urban Renewal - Residential Development LTD Logo Israel CSURE-M
YUHAN CORPORATION Logo
A pharmaceutical & chemical firm developing drugs, supplements, consumer products, and APIs.
South Korea 000100
YUKI GOSEI KOGYO CO.,LTD. Logo
Manufactures fine chemicals, amino acids, and APIs via organic synthesis for global industries.
Japan 4531

Talk to a Data Expert

Have a question? We'll get back to you promptly.